Please find attached a copy of presentation materials being used for a North American renewables valuation workshop with analysts this afternoon. An illustrative renewables valuation model to accompany the materials will be available at: https://infratil.com/for-investors/investor-days/
An illustrative fees model is also available at the same link to assist analysts and investors with modelling Infratil’s management and incentive fee payments.
Enquiries should be directed to:
Matthew Ross
Deputy CFO
Email: matthew.ross@infratil.com
Authorised for release by:
Andrew Carroll
Infratil Chief Financial Officer
Related
Infratil Independent Valuation Update - 31 December 2025
Infratil Independent Valuation Update – 31 December 2025 Attached is an update on the independent valuations completed for three of Infratil’s portfolio companies as at 31 December 2025. Using the
Infratil Newsletter - February 2026
Attached is a copy of the latest Infratil Newsletter for investors. It includes commentary on progress at various portfolio companies and confirms completion of the sale process for two previously
CDC Independent Valuation - 31 December 2025
CDC Independent Valuation – 31 December 2025 CDC’s valuation increased in the quarter, supported by an additional 40MW of previously announced contracted capacity, the addition of 196MW of built operating